Mark A. Brockman

Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction

Daniel E. Kaufmann, Daniel G. Kavanagh, Florencia Pereyra et al. · Nature Immunology · 2007 · 507 citations

Autoimmune Disease, Disease Progression, Human Retrovirus +9

Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication

Arne Schneidewind, Mark A. Brockman, Ruifeng Yang et al. · Journal of Virology · 2007 · 313 citations · Full text

HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition

Toshiyuki Miura, Mark A. Brockman, Arne Schneidewind et al. · Journal of Virology · 2008 · 294 citations · Full text

Histocompatibility, Elite Controllers, Hla Immunogenetics +16

IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells

Mark A. Brockman, Douglas S. Kwon, Daniel P. Tighe et al. · Blood · 2009 · 276 citations · Full text

Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A

Mark A. Brockman, Arne Schneidewind, Matthew Lahaie et al. · Journal of Virology · 2007 · 259 citations · Full text

Primary Immunodeficiency, Allergy, Autoimmune Disease +15